The arcuate nucleus mediates GLP-1 receptor agonist liraglutide-dependent weight loss

Liraglutide is a glucagon-like peptide-1 (GLP-1) analog marketed for the treatment of type 2 diabetes. Besides lowering blood glucose, liraglutide also reduces body weight. It is not fully understood how liraglutide induces weight loss or to what degree liraglutide acts directly in the brain. Here,...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Secher, Anna, Jelsing, Jacob, Baquero, Arian F., Hecksher-Sørensen, Jacob, Cowley, Michael A., Dalbøge, Louise S., Hansen, Gitte, Grove, Kevin L., Pyke, Charles, Raun, Kirsten, Schäffer, Lauge, Tang-Christensen, Mads, Verma, Saurabh, Witgen, Brent M., Vrang, Niels, Bjerre Knudsen, Lotte
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: American Society for Clinical Investigation 2014
Konular:
Research Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4215190/
https://ncbi.nlm.nih.gov/pubmed/25202980
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/JCI75276
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller